Jim Simons Maia Biotechnology, Inc. Transaction History

Renaissance Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$1.1 - $2.55 $101,420 - $235,109	-92,200 Reduced 82.91%	19,000 $42,000
Q4 2023 Feb 13, 2024	BUY	$0.83 - $2.54 $92,296 - $282,448	111,200 New	111,200 $130,000
Q2 2023 Aug 11, 2023	SELL	$2.11 - $3.84 $20,783 - $37,824	-9,850 Reduced 47.7%	10,800 $24,000
Q1 2023 May 12, 2023	BUY	$3.06 - $4.84 $63,189 - $99,946	20,650 New	20,650 $71,000

2.23M

Ticker MAIA
Exchange
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,935,900
Market Cap $18.2M
Description
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.